In contrast to the melanocortin 4 receptor, the possible role of the melanocortin 3 receptor (MC3R) in regulating body weight is still debated. We have previously reported three mutations in the MC3R gene showing association with human obesity, but these results were not confirmed in a study of severe obese North American adults. In this study, we evaluated the entire coding region of MC3R in 839 severely obese subjects and 967 lean controls of Italian and French origin. In vitro functional analysis of the mutations detected was also performed. The total prevalence of rare MC3R variants was not significantly different in obese subjects when compared with controls (P 5 0.18). However, the prevalence of mutations with functional alterations was significantly higher in the obese group (P 5 0.022). In conclusions, the results of this large study demonstrate that in the populations studied functionally significant MC3R variants are associated with obesity supporting the current hypothesis that rare variants might have a stronger impact on the individual susceptibility to gain weight. They also underline the importance of detailed in vitro functional studies in order to prove the pathogenic effect of such variants. Further investigations in larger cohorts will be needed in order to define the specific phenotypic characteristics potentially correlated with reduced MC3R signalling   INTRODUCTION 
INTRODUCTION
The widespread increase in the prevalence of obesity is certainly driven by environmental changing, but it is now well recognized that genetic susceptibility may influence the outcome (1, 2) . Family and twin studies have shown that genetic factors contribute 40-70% to the variation in BMI (3, 4) . In recent years, genome-wide association studies have highlighted that several common variants with small effects (5 -8) contribute to the genetic predisposition to obesity and that, based on their allelic frequencies, the population attributable risk must be taken into consideration. In addition, rare variants associated, in mice and in humans, with a phenotype of severe early-onset obesity have been reported in genes coding for molecules participating in the pathways that regulate energy homeostasis (9 -20) . Among these genes, mutations in the melanocortin receptor 4 (MC4R) have a prevalence of 1 -6% in obese subjects, both children and adults, and this prevalence is always significantly higher than that reported in controls (18) (19) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Another melanocortin receptor, the melanocortin receptor 3 (MC3R), is expressed in the arcuate nucleus of the hypothalamus and, in rodents, has been implicated in the long-term energy homeostasis (12, 37) . The knock-out mouse for MC3R (MC3R-KO) is hypophagic and shows a peculiar phenotype of decreased linear growth, increased fat mass and decreased lean mass. Thus, high feed efficiency, and not hyperphagia, seems to contribute to the increased fat mass (12) . Despite the characterization of the obese phenotype in MC3R-KO, the role of the MC3R in human obesity is still discussed. To date, two common variants have been described, but they are not associated with any obesity-related phenotype and thus should be considered as benign polymorphisms (38) . The first reported mutation (39) was in vitro functionally active but did not segregate with obesity in the family (39) (40) (41) . We subsequently studied 290 severely obese adults and found three mutations that were not present in 215 normal weight controls. Two of these mutations segregated with obesity in the family members and one of them demonstrated in vitro functional consequences (42) . However, in that study, the control population was not screened for the entire coding region of the gene and, thus, the prevalence of rare variants in controls could not be determined. Recently, Calton et al. (22) investigated the prevalence and function of MC4R and MC3R mutations in two cohorts of North American severely obese and non-obese subjects. They confirmed that MC4R mutations are significantly associated with severe obesity in North American adults, but, in contrast to the previously published data, they did not support a similar role for MC3R mutations (22) . To evaluate the prevalence of MC3R mutations and their possible association with obesity in other populations, in this study we screened the entire coding region of the MC3R gene in a total of 1806 subjects of French and Italian origin. In addition, we also evaluated in vitro functional consequences of each detected mutations.
RESULTS

Prevalence and nature of MC3R rare variants
In order to investigate whether MC3R gene rare variants are associated with human obesity, we analysed the coding sequence of this gene in 1249 French and 557 Italian unrelated subjects. Table 1 shows the anthropometric characteristics of the subjects enrolled in the study. We identified subjects carrying the already reported T6K and the V81I variants which showed a near complete linkage disequilibrium. Their allelic frequency was 10 and 14% in the Italian and French population, respectively, in line with those detected in other Caucasian cohorts studied (43) (44) (45) (46) . As demonstrated in a previous study (42) , these variants do not have any effect on MC3R function. Five subjects were heterozygous for new synonymous sequence variants (F12F, S69S, L95L, I226I, Q270Q) that were not further analysed as they do not change the amino acid and, presumably, would not affect receptor signalling. In addition to the three rare variants previously described (42), we also identified eight missense mutations and a single nucleotide variant in the promoter of the gene, all found in an heterozygous state. Some of these rare variants were present only in the obese populations (T-4C, S17T, D158Y, V177I, A293T, T280S, I335S), others were identified only in normal weight subjects (I87T, R257S, L285V) and the variants L249F and X361S were present in both groups ( Table 2 ). The frequency of MC3R rare variants carriers was not statistically different between the Italian and French subjects both in the obese and control groups (Table 2) . Moreover, no statistically significant differences were observed when the frequency of rare variants carriers in total obese subjects (1.55%) was compared with that in total lean ones (0.83%) (P ¼ 0.18). In vitro functional analysis of MC3R variants In order to investigate the possible association between an impairment of MC3R signalling and obesity, we evaluated the functional consequences of all mutations identified. The T-4C variant lies in the promoter region of the gene, thus we postulated that it could affect protein production. The WT and mutated receptor containing the 5 ′ flanking region presenting the mutation were cloned and transiently transfected in HEK293 cells. Western-blot analysis demonstrated that very low levels of MC3R protein were present in the lysates of cells transfected with the mutated receptor ( Fig. 1 ). This nucleotide variant was present in two non-related French children of 15 and 13 years of age with BMI of 32 (BMI Z-score 3.3 SD) and 28.3 kg/m 2 (BMI Z-score 3.5 SD), respectively.
MC4R missense mutations associated with obesity lead to impaired receptor response to agonist stimulation, thus we used an in vitro assay to systematically compare the agonist activation of the MC3R variants identified in both obese and normal weight subjects to that of the WT receptor. A missense variant was considered to have functional implications when the mutated receptor showed an EC 50 significantly different from that of the WT receptor (P , 0.05) and/or an E max , 50% of WT receptor maximum activity. Based on these parameters, two mutations leaded to a complete inactivation of the receptor (D158Y and I335S) and two (S17T and T280S) leaded to a drastic decrease in the E max (30 and 15% of the WT receptor maximal response, respectively) ( Fig. 2A) . These four mutations were found in seven obese subjects who were not relatives. In contrast, the variants identified only in normal weight subjects or in both obese and normal weight subjects showed a receptor response curve similar to WT receptor (Fig. 2B) . Moreover, for two variants identified only in lean subjects (I87T and L285V), the maximal response was 154 and 142% of the maximal response of the WT receptor (Fig. 2C ). Based on these functional studies, the prevalence of carriers of mutations associated with a reduced MC3R signalling was higher in obese subjects than in correspondent controls both in French North Africans and in French and Italian Caucasians (Table 3 ). The carriers' frequencies were not statistically different among the three groups (P . 0.05) indicating absence of heterogeneity. Furthermore, a metaanalysis of the results obtained demonstrated that functionally significant MC3R mutations were associated with obesity (P ¼ 0.022) ( Table 3) . Table 4 shows some of the phenotypic characteristics of the obese carriers. It is worth note that seven of the nine carriers are adolescents with early-onset obesity.
In silico analysis of MC3R gene variants
To determine whether in silico approaches could also be used to evaluate the functional significance of MC3R gene variants, we used the computer mutation prediction programs PolyPhen (47) and Screening for Non-Acceptable Polymorphism (SNAP) (48) (49) (50) . The results of the in vitro assay and the in silico predictions are shown in Table 5 . It must be noted that there are a number of discrepancies between the in vitro functional evaluation and the in silico prediction. Both PolyPhen and SNAP programs correctly predicted the functional implications of the three mutations that almost abolished the response to the agonist (D158Y, I335S and T280S), but both programs failed to detect the functional importance of the S17T 
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Human Molecular Genetics, 2011, Vol. 20, No. 2 alteration. Moreover, for two mutations, the in silico prediction was not supported by the results of an altered in vitro signalling. These findings suggest that the in silico approaches cannot replace in vitro functional characterization.
DISCUSSION
This study confirms that MC3R rare variants are present in both obese and lean subjects with a non-significantly different prevalence in the two groups. However, further analysis of the functional consequences induced by the identified variants highlights that the prevalence of heterozygotes for functionally altered variants is significantly higher in the obese subjects when compared with controls. Indeed, five of the seven variants found only in obese subjects have in vitro functional alterations that reduce or completely abolish the agonist response. In contrast, none of the rare variants found in lean controls or in both groups shows a decreased in vitro functional activity. The MC3R is a melanocortin receptor closely related to the MC4R and expressed in the arcuate nucleus of the hypothalamus that is a locus of energy homeostasis control (12, 37) . For these reasons, it has been also considered key gene predisposing to obesity but in marked contrast with MC4R, its pathophysiological role is still debated.
In the mouse model, the MC3R-KO is associated with a milder phenotype than in MC4R-KO and is not clearly characterized. In a previous study, we reported three mutations in obese subjects that were not found in 215 lean controls (42) . Two of them segregated with obesity in the family members studied and one was associated with impairment of the in vitro agonist response (42) . Subsequently, Calton et al. (22) reported that the prevalence of rare MC3R variants with and without functional alterations was not significantly different in two large North American cohorts of obese and lean subjects. The results of the present study are partially in accordance with those reported in the North American cohorts. Indeed, we confirm that rare MC3R variants are also present in the control populations with a frequency similar to that of the obese group. Compared with the frequencies reported in the North American cohorts, the prevalence in our cohorts of European subjects is higher in both groups suggesting the potential role of ethnicity. However, the analysis of the in vitro functional effects of these variants showed that those causing partial or total impairment of MC3R signalling were present only in the obese population. Considering as benign polymorphisms the rare variants without functional implications and as mutations only the variants with functional abnormalities, the prevalence of MC3R mutations carriers was significantly different in the two groups (P ¼ 0.022). Taken together these findings, it is tempting to speculate that, as for MC4R, impairment of MC3R signalling is associated Overall P-value derived from the meta-analysis of the three studies. with human obesity. This hypothesis is in contrast with the conclusions of the study in the North American cohorts (22) . It is worth note that Calton et al. (22) based their conclusions on the results obtained with a single mutation (F82S) inducing impaired in vitro MC3R signalling and found in two normal weight individuals. The lean phenotype described in these MC3R mutation carriers could be the results of an incomplete penetrance. Similar findings were previously described for MC4R mutations. Indeed, Farooqi et al. (51) in a large study of children with early-onset obesity reported that, for some MC4R mutations, although all homozygotes were obese, only 68% of heterozygotes had an obese phenotype and this could not be explained by their in vitro function. They postulated that the penetrance of MC4R mutations may vary as function of ethnicity or genetic and environmental modifiers may have major effects in some pedigrees. The genetic background of the two European populations is different from that of the North America cohorts and this could be another reason for the differences among the two studies. In addition, we also evaluated obese children/adolescents with an earlier impact of the mutations on weight and this could explain the higher frequency of functionally significant MC3R mutations found in the present study.
The genotype-phenotype correlation in the carriers of MC3R inactivating mutations did not allow to associate a specific phenotype to these mutations. In the MC3R-KO mouse, hyperphagia is not present and the increased fat mass seems to derive from high feed efficiency. In obese subjects, it is difficult to achieve a real estimate of daily caloric intake as it is generally based on self-reported questionnaire and it is also difficult to assess the real energy expenditure. Thus, in humans, evaluation of the energy balance cannot be useful as in animals and cannot indicate the possible presence of high feed efficiency. Looking at the anthropometrics characteristics of the nine MC3R mutation carriers, it is worth note that seven of them are adolescents with early-onset obesity. This finding leads to speculate that, as for MC4R, the role of the MC3R in the development of obesity might be particularly important in childhood.
In conclusion, the results of this large study demonstrate that functionally significant MC3R variants are associated with obesity supporting the current hypothesis that rare variants might have a stronger impact on the individual susceptibility to gain weight. They also underline the importance of detailed in vitro functional studies in order to prove the pathogenic effect of such variants. In addition, our study demonstrates that these functional studies cannot be replaced by in silico approaches. However, evaluation in larger cohorts will be needed in order to precise the specific phenotypic characteristic potentially correlated with reduced MC3R signalling. It could be used to identify subgroups of patients for whom dedicated therapeutic strategies could be developed.
MATERIALS AND METHODS
Subjects
Italian population. The present study was conducted on 343 obese patients referred to the Division of General Medicine of the San Giuseppe Hospital, Istituto Auxologico Italiano (Verbania, Italy), for diagnostic or therapeutic problems related to obesity or its morbidity. The patient group (249 females and 94 males, mean age 40 + 12 years and mean BMI 44.8 + 7.0 kg/m 2 ) included the 290 subjects previously studied (42) . A control group of 214 Italian normal weight individuals (142 females, 72 males, mean age 36 + 12 years, and mean BMI 22.4 + 2.7 kg/m 2 ) was also screened. Obese patients and controls were all Caucasian from Northern Italy.
French populations. French obese and population-based control children were also recruited in France. A total of 479 obese children/adolescent living in the Paris area (319 females and 160 males, mean age 13.6 + 4.5 years, mean BMI Z-score 4.3 + 1.1 SD) were recruited at Trousseau 
For PolyPhen predictions: benign is denoted as '2', possibly damaging is denoted as '+' and probably damaging is denoted as '++'. For SNAP predictions: neutral is denoted as '-' and non-neutral as '+', both followed by (RI; % expected accuracy). For in vitro classification, no functional alterations is denoted as '-' and functional alterations as '+', followed by the difference observed from WT. . Obese children had a BMI Z-score ≥3 SD above the means specific for age and sex in normal French children as described previously (52, 53) . The control children participated in the Intervention Centred on Adolescent Physical Activity and Sedentary Behaviour (ICAPS) study (54) . Phenotypes were collected before the physical activity intervention. Three hundred and fifty-four subjects were selected among the participants of ICAPS. This intervention study aimed to promote physical activity in a representative sample of pre-adolescents (mean age 11.2 + 0.7 years) that initially included 4.8% obese subjects (54) . In addition, 416 non-obese control subjects (mean age 51 + 0.31 and mean BMI 22. Obese subjects and the controls were matched for ethnicity (70% Caucasian, 30% North African).
The study protocol was approved by the Ethics Committees of the Institutions involved. The aim and the design of the study were explained to the patients who gave their informed consent.
MC3R gene mutation screening
Three sets of primers (MC3R-B 5
′ -TCTCTCTACCCTCCC CATCC-3 ′ and MC3R-BR 5
were used in a PCR reaction to amplify three overlapping fragments covering the entire MC3R coding region. The PCR was performed using the following conditions: denaturation at 958C for 10 min, followed by 35 cycles of denaturation at 958C for 30 s, annealing at 61.3, 58.3 and 55.58C for 30 s for the three fragments, respectively, and elongation at 728C for 50 s followed by a final elongation of 7 min. The PCR fragments were analysed by Denaturing High Performance Liquid Chromatography (Wave-System, Transgenomic, Inc.) and eventually sequenced using the BigDye Teminator Kit (Applied Biosystem, Foster City, CA, USA) and analysed on the ABI Prism 310 automated sequencer (Applied Biosystem).
Cloning of wild-type and mutated MC3R
The entire coding region of the MC3R gene was amplified using MC3R-B and MC3R-R2 primers and the PCR product was cloned into a pcDNA3.3 TOPO TA vector (Invitrogen). The mutated constructs were obtained by site-directed mutagenesis of MC3R WT construct using the QuickChange SiteDirected Mutagenesis Kit (Stratagene, La Jolla, CA, USA). The WT sequence and the presence of mutations were confirmed by sequence analysis.
Intracellular cAMP determination
Ligand-stimulated receptor activity was evaluated by determining the intracellular cAMP content after stimulation with alpha-melanocortin stimulating hormone (a-MSH). HEK 293 cells were maintained in DMEM:F12 1:1 medium supplemented with 10% calf serum (HYCLONE, Logan, UT, USA), L-glutamine, penicillin/ streptomycin. The day before transfection, 200 000 cells/well were plated in six-well plates. The following day, the cells were transfected with 500 ng of pcDNA3.3-MC3R plasmid and 50 ng of pGL3 Control Vector (Promega Corporation, Madison, WI, USA) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. After 24 h, cells were washed and splitted in a 96-well plate and 48 h after transfection they were incubated in a stimulation medium composed of DMEM with 0.25 mM IBMX and varying concentrations of a-MSH (Sigma, St Louis, MO, USA) for 1 h at 378C in a 5% CO 2 incubator. Following the incubation, cells were lysed and intracellular cAMP was determined by Amersham cAMP Biotrak Enzymeimmunoassay (EIA) System (GE Healthcare). An aliquot of the cell lysate was used to determine luciferase production as transfection control with Steady-Glo Luciferase Assay System (Promega Corporation).
Each experiment was performed in triplicate and repeated at least three times.
Western-blot analysis of MC3R
WT and T-4C pcDNA3.3-MC3R vectors were transfected in HEK293 cells as described above. Twenty-four hours after transfection, cell lysates were collected and size separated by 10% SDS-PAGE (Criterion, Biorad). Western blot was performed using a polyclonal antibody directed against Human MC3-R (Alpha Diagnostic, TX, USA) and the results were normalized by the total protein content of lysates determined by the BCA test (Thermo Scientific, IL, USA).
In silico prediction of missense mutations effects
PolyPhen prediction: missense variants identified by sequencing were classified based on their potential impact on protein function or structure (benign, possibly damaging, or probably damaging) using a new version of the PolyPhen method (47) . These predictions are based on the analysis of multiple sequence alignments of homologous proteins, functional annotation and structural information if available (47) . The new version of PolyPhen constructs multiple sequence alignment using a pipeline of several existing programs for aligning sequences, alignment quality control and clustering of sequences.
SNAP prediction: SNAP (Screening for Non-Acceptable Polymorphisms) is a neural-network-based method (49) that uses information about sequence conservation, per residue predictions of secondary structure, solvent accessibility and flexibility, and, if available, experimental functional annotations. The server output is a binary classification of the mutation's functional effect (neutral/non-neutral) in combination with the reliability index (RI) of prediction (integer score ranging Human Molecular Genetics, 2011, Vol. 20, No. 2 397 from zero to nine) (48) , which correlates well with the expected accuracy of the prediction (50) .
Statistical analysis
The prevalence of rare MC3R mutation carriers and of functionally significant rare mutations carriers in severely obese subjects and lean subjects were analysed by exact Fisher's test. Fisher's weighted Z-score test was used for the meta-analysis of the data obtained in the different cohorts. Best-fit estimates of the ligand concentration needed to achieve 50% of maximum effect (EC50s) were obtained by non-linear regression fitting of the dose -response curves using GraphPad Statistics Software. Differences in EC50 of mutant receptors and wild-type receptors were analysed by ANOVA and Dunnett's post-test. A P-value ,0.05 was assumed as statistical significant.
